Etravirine cost effective for multidrug resistant HIV-1

February 2010
PharmacoEconomics & Outcomes News;2/6/2010, Issue 596, p6
The article summarizes the findings of the study "Cost-effectiveness of Etravirine in Sweden in Treatment-experienced HIV-1-infected Adults with Evidence of NNRTI Resistance and 3 PI Mutations," by K. Moeremans et al.


Related Articles

  • Changes in symptoms and health-related quality of life in a nationally representative sample of adults in treatment for HIV. Lorenz, Karl A.; Cunningham, William E.; Spritzer, Karen L.; Hays, Ron D. // Quality of Life Research;Aug2006, Vol. 15 Issue 6, p951 

    Patient-centered measures of functioning and well-being are needed to monitor and improve health for HIV-infected persons. We estimated the associations between HRQOL and symptoms over time in HIV-infected persons, adjusting for demographic and clinical characteristics using a longitudinal study...

  • Outcomes of HIV Infection in Persons Who Resume Treatment after Interruptions.  // Annals of Internal Medicine;9/2/2008, Vol. 149 Issue 5, pI-30 

    The article presents a study to assess the risk for HIV-related infection and illness in persons receiving interrupted treatment who start continuous treatment. HIV-infected persons in 33 countires were assigned at random to receive continuous or interrupted treatment. The study found the blood...

  • Rates of inappropriate antiretroviral prescription among injection drug users. Wood, Evan; Hogg, Robert S.; Kerr, Thomas; Bonner, Simon; Strathdee, Steffanie A.; Palepu, Anita; Montaner, Julio S. G. // Harm Reduction Journal;2007, Vol. 4, p2 

    Background: Although the survival benefits of antiretroviral therapy (ART) for the treatment of HIV infection are well established, the clinical management of HIV disease continues to present major challenges. There are particular concerns regarding access to appropriate HIV treatment among...

  • Is gene therapy a good therapeutic approach for HIV-positive patients? Marathe, Jai G.; Wooley, Dawn P. // Genetic Vaccines & Therapy;2007, Vol. 5, p1 

    Despite advances and options available in gene therapy for HIV-1 infection, its application in the clinical setting has been challenging. Although published data from HIV-1 clinical trials show safety and proof of principle for gene therapy, positive clinical outcomes for infected patients have...

  • Profile: Michael Malim. Mandavilli, Apoorva // Nature Medicine;Jun2005, Vol. 11 Issue 6, p586 

    The article reports on the work of researcher Michael Malim, who has been working in pursuit of a protein that can stop HIV in its tracks. Malim is one of a group of HIV researchers, who play puerile practical jokes on each other, some of which have involved mattresses dragged into bathtubs,...

  • Development of Opportunistic Infections After Diagnosis of Active Tuberculosis in HIV-Infected Patients. Kwara, Awewura; Carter, E. Jane; Rich, Josiah D.; Flanigan, Timothy P. // AIDS Patient Care & STDs;Jun2004, Vol. 18 Issue 6, p341 

    Despite advances in highly active antiretroviral therapy (HAART), its use during tuberculosis (TB) treatment is fraught with challenges, often leading to delayed therapy. This report describes the course of HIV infection and outcomes of 26 consecutive TB/HIV coinfected patients who received TB...

  • New class of anti-HIV drugs. Stephenson, Joan; Stephenson, J // JAMA: Journal of the American Medical Association;12/1/99, Vol. 282 Issue 21, p1994 

    Reports attempts by medical researchers in California to develop an alternative class of anti-HIV drugs, called fusion inhibitors, for those patients who fail to respond to the standard anti-HIV drugs. How fusion inhibitors are designed to work; Results of a preliminary study involving a fusion...

  • F Y I.  // Gay & Lesbian Times;3/23/2006, Issue 952, p30 

    The article reports on the discovery made by Ohio State University scientists that could possibly be the cure for HIV infections and AIDS. The scientists have discovered a previously unknown mechanism that cells use to fight off HIV. It indicated two proteins that can destroy cellular DNA made...

  • Stability of the Latent Reservoir for HIV-1 in Patients Receiving Valproic Acid. Siliciano, Janet D.; Jun Lai; Callender, Marc; Pitt, Eleanor; Hao Zhang; Margolick, Joseph B.; Gallant, Joel E.; Cofrancesco Jr., Joseph; Moore, Richard D.; Gange, Stephen J.; Siliciano, Robert F. // Journal of Infectious Diseases;3/15/2007, Vol. 195 Issue 6, p833 

    In light of a recent report that short-term treatment with valproic acid (VA) might accelerate the decay of the latent reservoir for HIV-1 in patients receiving combination therapy and allow eventual eradication of the infection, we studied patients with prolonged suppression of viremia who were...

  • Crocodile blood kills HIV.  // Advocate;9/27/2005, Issue 947, p22 

    This article reports that crocodile blood kills HIV. Scientists in Australia's tropical north are collecting the blood after discovering that the immune system of crocodiles there is much more powerful than that of humans, preventing life-threatening infections after savage territorial fights....


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics